QMS Medical Allied Services share news and announcements
NSE: QMSMEDIHealthcare Equipment & SuppliesSmall Cap
Last close ₹172.21down ₹3.18 (1.81%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹175.39.
52-week range of traded prices to 23 Oct 2026
₹68.95Low, 17 Mar 2026₹216.79High, 29 Sep 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹333 Cr2,417th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 3.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.29%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.65
- Volume, NSEVolume. Shares traded on the last trading day.
- 99,817
QMS Medical Allied Services record dates, bonuses and splits
10 filed, newest first.
Sep 2026
7 Sep · Corporate action
Sep 2025
10 Sep · Corporate action
Aug 2025
29 Aug · Corporate action
29 Aug · Corporate action
Sep 2024
4 Sep · Corporate action
Sep 2023